Common short-acting GLP-1s include exenatide, liraglutide, and lixisenatide
We will continue to push forward, Dr
In the landmark Phase 3 VESALIUS-CV trial (12,000+ patients), adding Repatha to standard cholesterol-lowering therapy significantly reduced the risk of: Heart attacks Ischemic strokes Coronary deaths This makes Repatha the first PCSK9 inhibitor to demonstrate preventive benefits before heart disease strikes a true paradigm shift in cardiovascular care
Skin111s Skin, Hair and Nails IV Drip blends glutathione, biotin, and 9 trace minerals to brighten skin, support hair growth, and strengthen nails, plus boost energy and detoxification
Our taste buds make eating pleasurable and the oral satisfaction of eating is primal
This issue is not just a public health priority but also a workforce and economic imperative